JOURNAL HOME CME HOME THIS MONTH PAST ISSUES ETOC COLLECTIONS
AUTHORS REVIEWERS EDITORIAL BOARD FEEDBACK RSS HELP
A&A International Anesthesia Research Society
 QUICK SEARCH:   [advanced]


     


This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a colleague
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via ISI Web of Science (12)
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Schmid, E. R.
Right arrow Articles by Seifert, B.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Schmid, E. R.
Right arrow Articles by Seifert, B.
Anesth Analg 1999;89:1108
© 1999 International Anesthesia Research Society


CARDIOVASCULAR ANESTHESIA

Inhaled Nitric Oxide Versus Intravenous Vasodilators in Severe Pulmonary Hypertension After Cardiac Surgery

Edith R. Schmid, MD*, Christoph Bürki, MD*, Markus H. C. Engel, MD*, Daniel Schmidlin, MD*, Mico Tornic, MD*, and Burkhardt Seifert, PhD{dagger}

*Division of Cardiovascular Anesthesia, Institute of Anesthesiology, University Hospital of Zurich; and {dagger}Department of Biostatistics, University of Zurich, Zurich, Switzerland

Address correspondence and reprint requests to Edith R. Schmid, MD, Division of Cardiovascular Anesthesia, Institute of Anesthesiology, University Hospital, CH-8091 Zürich, Switzerland. Address e-mail to edith.schmid{at}ifa.usz.ch

Inhaled nitric oxide (iNO) is superior to i.v. vasodilators for treatment of pulmonary hypertension (PH) after cardiac surgery, but iNO is a potentially toxic gas, and patient subsets who benefit from iNO are not yet clearly defined. We administered iNO 40 ppm, prostaglandin E1 (PGE1) 0.1 µg · kg-1 · min-1, and nitroglycerin (NTG) 3 to 5 µg · kg-1 · min-1, in a randomized crossover study to 14 adult patients with severe PH after cardiac surgery. iNO, PGE1, and NTG were of similar efficacy in reducing pulmonary vascular resistance (P = 0.003). iNO induced selective pulmonary vasodilation, while PGE1 and NTG had significant concomitant systemic vasodilatory effects. iNO led to an increase in cardiac index (CI) (P = 0.012), and PGE1 increased CI (P = 0.006) and right ventricular (RV) ejection fraction (P = 0.015), while NTG had no effect on CI and RV performance. After study completion, patients continued with PGE1 administration with favorable in-hospital outcome. We conclude that PH per se, even if severe, does not necessarily imply postoperative RV dysfunction, and selective pulmonary vasodilation with iNO may not be superior to PGE1 with regard to CI and RV performance.

Implications: In a prospective, randomized crossover study of inhaled nitric oxide (iNO) versus IV vasodilators, performed in adult patients with severe pulmonary hypertension but preserved right ventricular function after cardiac surgery, iNO was not superior to IV prostaglandin E1 with regard to cardiac index and right ventricular performance. Considering the potential toxicity of iNO, better definition of patient subsets with a positive benefit/risk ratio is warranted.




This article has been cited by other articles:


Home page
Ann. Thorac. Surg.Home page
S. Nemoto, E. Umehara, T. Ikeda, T. Itonaga, and M. Komeda
Oral Sildenafil Ameliorates Impaired Pulmonary Circulation Early After Bidirectional Cavopulmonary Shunt
Ann. Thorac. Surg., May 1, 2007; 83(5): e11 - e13.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
P. Goyal, U. Kiran, S. Chauhan, R. Juneja, and M. Choudhary
Efficacy of nitroglycerin inhalation in reducing pulmonary arterial hypertension in children with congenital heart disease
Br. J. Anaesth., August 1, 2006; 97(2): 208 - 214.
[Abstract] [Full Text] [PDF]


Home page
Br J AnaesthHome page
E. B. Lobato, T. Beaver, J. Muehlschlegel, D. S. Kirby, C. Klodell, and A. Sidi
Treatment with phosphodiesterase inhibitors type III and V: milrinone and sildenafil is an effective combination during thromboxane-induced acute pulmonary hypertension
Br. J. Anaesth., March 1, 2006; 96(3): 317 - 322.
[Abstract] [Full Text] [PDF]


Home page
J. Thorac. Cardiovasc. Surg.Home page
C. Joffs, C. A. Walker, J. W. Hendrick, D. J. Fary, D. K. Almany, J. N. Davis, A. T. Goldberg, F. A. Crawford Jr, and F. G. Spinale
Endothelin receptor subtype A blockade selectively reduces pulmonary pressure after cardiopulmonary bypass
J. Thorac. Cardiovasc. Surg., August 1, 2001; 122(2): 365 - 370.
[Abstract] [Full Text] [PDF]




Lippincott, Williams & Wilkins Anesthesia & Analgesia® is published for the International Anesthesia Research Society® by Lippincott Williams & Wilkins with the assistance of Stanford University Libraries' HighWire Press®. Copyright 2006 by the International Anesthesia Research Society. Online ISSN: 1526-7598   Print ISSN: 0003-2999 HighWire Press
Copyright © 1999 by the International Anesthesia Research Society.